Semax 10mg – ACTH-Derived Peptide

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10) and studied in laboratory research for its role in neurochemical signalling and central nervous system regulatory pathways. It is structurally modified to enhance stability and duration in experimental settings.

In research literature, Semax is examined in models investigating neuroendocrine signalling, peptide-mediated modulation mechanisms, and central nervous system regulatory processes.

This 10mg lyophilized formulation is supplied at ≥99% purity and intended strictly for laboratory research purposes.

Key Features

• 10mg lyophilized Semax
• Synthetic ACTH-derived peptide fragment
• ≥99% purity
• Research use only
• Discreet Australian shipping

Mechanism Overview

Semax is structurally based on the ACTH 4–10 fragment and is studied for its interaction with neurochemical and neuroendocrine signalling pathways. Research suggests involvement in peptide-mediated regulatory mechanisms within central nervous system experimental models.

Its structural modification enhances stability compared to naturally occurring fragments, positioning Semax as a compound of interest in laboratory investigations involving neuroregulatory signaling.

Stability and Handling

Semax is supplied in lyophilized (freeze-dried) form to preserve stability during storage and transport. Standard laboratory handling practices include:

• Refrigerated storage following reconstitution
• Protection from light exposure
• Avoiding repeated temperature fluctuations

Maintaining cold-chain integrity is particularly important in Australian shipping environments.

Research Use Only

Semax is supplied strictly for laboratory research and educational purposes. It is not approved for therapeutic use and is not intended for human consumption.